144089-96-3

Basic information

• Product Name: DMT-2'-F-dGiBu
• Synonyms: DMT-2'-F-dGiBu;N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide;5'-DMT-2'-F-ibu-dG;5-O-DMT-N2-ISOBUTYRYL-2-FLUORO-2-DEOXYGUANOSINE
• CAS NO: 144089-96-3
• Molecular Formula: C₃₅H₃₆FN₅O₇
• Molecular Weight: 657.6880432
• Mol File: 144089-96-3.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Density: 1.38±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 9.16±0.20(Predicted)
• CAS DataBase Reference: DMT-2'-F-dGiBu(CAS DataBase Reference)
• NIST Chemistry Reference: DMT-2'-F-dGiBu(144089-96-3)
• EPA Substance Registry System: DMT-2'-F-dGiBu(144089-96-3)

Safety Data

• Hazardous Substances Data: 144089-96-3(Hazardous Substances Data)

Usage

Description

DMT-2'-F-dGiBu is a chemical compound that is a modification of the psychedelic substance DMT (N,N-Dimethyltryptamine). It is a tryptamine derivative known for its hallucinogenic effects, producing profound alterations in perception, mood, and cognition. DMT-2'-F-dGiBu features a fluoro substitution at the 2' position of the indole ring and a butyl group attached to the dimethylamine moiety, which is thought to enhance the potency and duration of the psychoactive effects of DMT.

Uses

Used in Psychedelic Research:
DMT-2'-F-dGiBu is used as a research chemical for studying the effects of DMT on the brain and consciousness. Its enhanced potency and duration of psychoactive effects make it a valuable tool for investigating the mechanisms of action and potential therapeutic applications of psychedelic substances.
Used in Pharmaceutical Development:
DMT-2'-F-dGiBu has the potential to be developed into a pharmaceutical drug for the treatment of various mental health conditions. Its unique properties and effects on perception, mood, and cognition may offer new avenues for the development of novel therapeutic agents.
Used in Spiritual and Personal Growth Practices:
DMT-2'-F-dGiBu, like other psychedelic substances, may be used in spiritual and personal growth practices to explore consciousness, enhance self-awareness, and facilitate personal transformation. Its profound effects on perception and cognition can provide users with unique insights and experiences that may contribute to personal development and spiritual growth.

Upstream product

• 40615-36-9 4,4'-dimethoxytrityl chloride 
• 80681-25-0 2’-fluoro-N2-isobutyryl-2’-deoxyguanosine 
• 69304-44-5 3',5'-O-1,1,3,3-tetraisopropyldisiloxan-1,3-diyl-guanosine 
• 129835-15-0 2-amino-9-((6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl)-1H-purin-6(9H)-one 
• 146954-66-7 N²-isobutyryl-9-(2-O-isobutyryl-β-D-arabinofuranosyl)guanine 
• 146954-68-9 N²-isobutyryl-9-(3,5-di-O-tetrahydropyran-2-yl-β-D-arabinofuranosyl)guanine 
• 146954-69-0 N²-isobutyryl-9-(2-fluoro-3,5-di-O-tetrahydropyran-2-yl-β-D-arabinofuranosyl)guanine 
• 146954-67-8 Isobutyric acid (2R,3S,4R,5R)-2-(2-isobutyrylamino-6-oxo-1,6-dihydro-purin-9-yl)-4-(tetrahydro-pyran-2-yloxy)-5-(tetrahydro-pyran-2-yloxymethyl)-tetrahydro-furan-3-yl ester 
• 146954-65-6 N²-isobutyryl-9-(2-O-isobutyryl-3,5-O-(tetraisopropyldisiloxanylene)-β-D-arabinofuranosyl)guanine 
• 200404-37-1 Trifluoro-methanesulfonic acid (2R,3S,4R,5R)-2-(2-isobutyrylamino-6-oxo-1,6-dihydro-purin-9-yl)-4-(tetrahydro-pyran-2-yloxy)-5-(tetrahydro-pyran-2-yloxymethyl)-tetrahydro-furan-3-yl ester 
• 129835-17-2 9-[3',5'-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-arabinofuranosyl]guanine 
• 78842-13-4 2'-deoxy-2'-fluoroguanosine 

Downstream Products

• 1337865-42-5 C₄₄H₄₃FN₈O₉ 

Relevant articles and documents

2′-Fluoro-c-di-GMP as an oral vaccine adjuvant

Bis-(3′-5′)-cyclic dimeric 2′-deoxy-2′-fluoroguanosine monophosphate (2′-F-c-di-GMP) was synthesized through the modified H-phosphonate chemistry. Oral immunization of C57BL/6 mice with Helicobacter pylori cell-free sonicate extract adjuvanted with 2′-F-c

COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE" -DEPENDENT SIGNALLING

The present invention provides highly active cyclic-di-nucleotide (CDN) immune stimulators that activate DCs via a recently discovered cytoplasmic receptor known as STING (Stimulator of Interferon Genes), In particular, the CDNs of the present invention a